Peerapon H. Wong
Phitsanulok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Mucosal-Associated Lymphoid Tissue Lymphoma in Southeast Asia: A 15-Year Retrospective Multicenter Study.
Journal: Hematology reports
Published: August 29, 2025
Optimizing Markers for Chronic Lymphocytic Leukemia Diagnosis by Flow Cytometry: Results From the Nationwide Thai Lymphoma Study Group.
Journal: Journal of clinical laboratory analysis
Published: March 31, 2025
Clinical characteristics, laboratory features and genetic profile of hemoglobin E (HBB:c.79 G > A)/β (nucleotide -28 A > G) (HBB:c.-78 A > G) -thalassemia subjects identified from community- and hospital-recruited cohorts.
Journal: Blood cells, molecules & diseases
Published: May 07, 2024
Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry.
Journal: Annals of hematology
Published: April 28, 2024
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group.
Journal: Annals of hematology
Published: June 29, 2023
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG).
Journal: Annals of hematology
Published: April 07, 2023
Essential genetic modifiers and their measurable impact in a community-recruited population analysis for non-severe hemoglobin E/β-thalassemia prenatal genetic counseling.
Journal: Blood cells, molecules & diseases
Published: February 28, 2023
Prevalence and predictors of peripheral arterial disease determined by ankle brachial index in diabetes population treated within primary care services in a non-urban area of lower northern Thailand.
Journal: Diabetes & vascular disease research
Published: November 07, 2020
Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group.
Journal: Leukemia & lymphoma
Published: June 24, 2020
Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma.
Journal: Hematological oncology
Published: August 28, 2019
Last Updated: 09/26/2026